Literature DB >> 18212285

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Ralph B D'Agostino1, Ramachandran S Vasan, Michael J Pencina, Philip A Wolf, Mark Cobain, Joseph M Massaro, William B Kannel.   

Abstract

BACKGROUND: Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents. METHODS AND
RESULTS: We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non-laboratory-based predictors.
CONCLUSIONS: A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.

Entities:  

Mesh:

Year:  2008        PMID: 18212285     DOI: 10.1161/CIRCULATIONAHA.107.699579

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2000 in total

1.  Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness.

Authors:  Joseph C Ratliff; Laura B Palmese; Erin L Reutenauer; Vinod H Srihari; Cenk Tek
Journal:  Psychosomatics       Date:  2012-06-02       Impact factor: 2.386

2.  Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.

Authors:  Mandip S Dhamoon; Mitchell S V Elkind
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

3.  Comparability of total cardiovascular disease risk estimates using laboratory and non-laboratory based assessments in urban-dwelling South Africans: the CRIBSA study.

Authors:  Nasheeta Peer; Carl Lombard; Krisela Steyn; Thomas Gaziano; Naomi Levitt
Journal:  S Afr Med J       Date:  2014-08-13

4.  Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.

Authors:  Samia Mora; Nanette K Wenger; Nancy R Cook; Jingmin Liu; Barbara V Howard; Marian C Limacher; Simin Liu; Karen L Margolis; Lisa W Martin; Nina P Paynter; Paul M Ridker; Jennifer G Robinson; Jacques E Rossouw; Monika M Safford; JoAnn E Manson
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

5.  Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

Authors:  Saro H Armenian; Dongyun Yang; Jennifer Berano Teh; Liezl C Atencio; Alicia Gonzales; F Lennie Wong; Wendy M Leisenring; Stephen J Forman; Ryotaro Nakamura; Eric J Chow
Journal:  Blood Adv       Date:  2018-07-24

6.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

7.  Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study.

Authors:  Ramin Farzaneh-Far; Beeya Na; Nelson B Schiller; Mary A Whooley
Journal:  Atherosclerosis       Date:  2008-12-30       Impact factor: 5.162

8.  Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.

Authors:  Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-02-28       Impact factor: 2.680

9.  Discrepancies between two lipid-lowering guidelines for CVD prevention in seemingly healthy individuals-case study Lebanon.

Authors:  Hussain Ali Isma'eel; Bernard Harbieh; Hani Tamim; Lara Nasreddine; Farah Naja; Abla Sibai; Nada Adra; Kamal Badr; Nahla Hwalla
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

10.  Temporal Associations Between Smoking and Cardiovascular Disease, 1971 to 2006 (from the Framingham Heart Study).

Authors:  Gordon M Burke; Michael Genuardi; Heather Shappell; Ralph B D'Agostino; Jared W Magnani
Journal:  Am J Cardiol       Date:  2017-08-08       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.